Table 2

Ocular characteristics of participants in the UK Biobank at baseline visit and at the first repeat visit

Type of eye testSummary measureBaseline visitFirst repeat visit
DescriptionNMean±SD/(%)NMean±SD/(%)
Visual acuityMean±SD LogMAR in RE116 0680.03±0.2120 1620.00±0.21
Mean±SD LogMAR in LE116 0710.02±0.2120 1530.00±0.22
RefractionMean±SD spherical equivalent in RE (D)114 269−0.36±2.7419 505−0.34±2.86
Mean±SD spherical equivalent in LE (D)113 895−0.30±2.7619 381−0.31±2.90
No of non-myopes (≤−0.50 D)69 87160.811 63659
No (%) of low myopes (≤−2.99 D)*27 04823.5465623.6
No (%) of moderate myopes (≤−3.00 to ≥−5.99 D)*12 03310.5233611.8
No (%) of high myopes (≤−6.00 D)*59175.210955.6
Ocular Response AnalyzerMean±SD IOPg in RE (mm Hg)112 29215.88±3.9719 51516.19±4.28
Mean±SD IOPg in LE (mm Hg)111 96115.74±4.0219 46016.05±4.30
Mean±SD IOPcc in RE (mm Hg)112 29216.08±4.3519 51516.52±5.05
Mean±SD IOPcc in LE (mm Hg)111 96216.01±4.4019 46016.00±4.84
No (%) of ocular hypertension (IOPg >21 mm Hg)†14 19212.5318216.2
  • *Myopia severity defined from either eye.

  • †Ocular hypertension defined from either eye.

  • IOPcc, corneal-compensated intraocular pressure; IOPg, Goldmann-correlated intraocular pressure; LE, left eye; LogMAR, logarithm of the minimum angle of resolution; RE, right eye.